The experts will assess unblinded data from BEACON-IPF to figure out why a data safety monitoring board recommended ...

In a recent transaction, Allen S. Melemed, the Chief Medical (TASE:PMCN) Officer of Chimerix Inc . (NASDAQ:CMRX), sold 3,065 shares of the company's common stock. The shares were sold at an average ...

Ma Songjiang, President of Gyre Therapeutics, Inc. (NASDAQ:GYRE), a $1.03 billion market cap biotech company, executed sales of common stock valued at a total of $46,360 over two consecutive days, ...

Nerandomilast worked better than a placebo to preserve lung function in adults with progressive pulmonary fibrosis in a Phase 3 study.

Patients with progressive pulmonary fibrosis who received nerandomilast showed improved forced vital capacity from baseline ...

U.S.-based PleoPharma announced yesterday that the FDA has granted it a fast-track designation for PP-01, a new ...

It’s the first FDA approval for a pain medication in 25 years. How does the drug work, and who is it for?

Ossification of the posterior longitudinal ligament (OPLL) is a progressive spinal disease characterized by ectopic bone ...

The discovery opens up opportunities to study the therapeutic properties of ibogaine and related compounds. Ibogaine, a ...

The President's Emergency Plan for AIDS Relief has been the subject of a series of presidential orders and memos that have ...

Kepler Capital analyst Justine Telliez maintained a Hold rating on Innate Pharma SA (IPHYF – Research Report) on February 12 and set a price ...

An expert discusses the current understanding of corticosteroids in managing pulmonary fibrosis and how it has evolved in ...